Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your agenda.
This session is in your agenda. Click to remove it
Back
Favorite
0
Like
Facebook
Tweet
Print
Chengcheng Liu, PhD
Director, Statistics
AbbVie
Madison, New Jersey
Disclosure information not submitted.
Presentation(s):
Efficacy of Ubrogepant for the Treatment of Migraine Symptoms During the Prodrome (Premonitory Phase): Results From the PRODROME Trial
POSTER ABSTRACT
Ubrogepant for the Acute Treatment of Migraine When Administered During the Prodrome (Premonitory Phase): Results From a Phase 3, Randomized, Double-blind, Placebo-Controlled, Crossover Study
POSTER ABSTRACT
